Literature DB >> 32629235

A systematic review on the association between obstructive sleep apnea and chronic kidney disease.

Ilaria Umbro1, Valerio Fabiani2, Mario Fabiani3, Francesco Angelico4, Maria Del Ben5.   

Abstract

This systematic review aims to provide a more comprehensive overview of the association between obstructive sleep apnea (OSA) and chronic kidney disease (CKD). A PubMed search was conducted using the terms "(obstructive sleep disorders OR obstructive sleep apnea OR obstructive sleep apnea syndrome) AND (kidney function OR renal outcome OR chronic kidney disease OR end stage renal disease)". Four hundred seventy four articles were initially retrieved, 227 in the last five years. We included articles with similar definitions of OSA, in particular only diagnosed by polysomnography, in order to exclude bias related to different diagnostic clinical tools, prediction algorithms and questionnaires that affected previous studies. Six cross-sectional and two retrospective studies were analyzed. There were a total of 8795 participants across all the studies with a mean age between 51 and 63 years. One study included only males but the proportion of males in the other studies ranged from 58 to 85.6%. The mean body mass index ranged from 25.2 to 32 kg/m2. The majority of studies considered indicate that OSA and CKD are significantly associated, in particular in their more severe categories. It is of great importance to set up a strong clinical collaboration between sleep medicine and nephrology.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Obstructive sleep apnea; Obstructive sleep disorders; Polysomnography; Renal function; Sleep apnea

Mesh:

Year:  2020        PMID: 32629235     DOI: 10.1016/j.smrv.2020.101337

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  7 in total

1.  Risk of chronic kidney disease in patients with obstructive sleep apnea.

Authors:  Andrew E Beaudin; Jill K Raneri; Sofia B Ahmed; A J Marcus Hirsch Allen; Andrhea Nocon; Teresa Gomes; Simon Gakwaya; Fréderic Series; John Kimoff; Robert P Skomro; Najib T Ayas; Patrick J Hanly
Journal:  Sleep       Date:  2022-02-14       Impact factor: 5.849

Review 2.  Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment.

Authors:  L Parker Gregg; Maurizio Bossola; Mauricio Ostrosky-Frid; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-15       Impact factor: 10.614

3.  The mediating effect of sleep quality and fatigue between depression and renal function in nondialysis chronic kidney disease: a cross-sectional study.

Authors:  Ya-Fang Ho; Pei-Ti Hsu; Kai-Ling Yang
Journal:  BMC Nephrol       Date:  2022-03-31       Impact factor: 2.388

4.  Sleep Patterns, Genetic Susceptibility, and Incident Chronic Kidney Disease: A Prospective Study of 370 671 Participants.

Authors:  Haojie Zhang; Bin Wang; Chi Chen; Ying Sun; Jie Chen; Xiao Tan; Fangzhen Xia; Jihui Zhang; Yingli Lu; Ningjian Wang
Journal:  Front Neurosci       Date:  2022-01-31       Impact factor: 4.677

5.  Effects of Surgical Treatment for Obstructive Sleep Apnea on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study.

Authors:  Juen-Haur Hwang; Ben-Hui Yu; Yi-Chun Chen
Journal:  J Clin Med       Date:  2022-07-29       Impact factor: 4.964

6.  Changing Effects of Minimally Invasive Surgical Intervention on ALT, AST, and UA in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome.

Authors:  Liang-Cai Yu; Xin Zhao; Li-Jun Liu; Xiao-Ying Li; Jin Zhou; Ping Zeng; Xiao-Qing Zhang
Journal:  Int J Clin Pract       Date:  2022-07-14       Impact factor: 3.149

7.  Comparison of Jaw Elevation Device vs. Conventional Airway Assist during Sedation in Chronic Kidney Diseases Undergoing Arteriovenous Fistula Surgery: A Randomized Controlled Trial.

Authors:  Sang Hyun Lee; Ji Seon Jeong; Jaeni Jang; Young Hee Shin; Nam-Su Gil; Ji-Won Choi; Tae Soo Hahm
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.